CLEC2D and rheumatoid arthritis: Prior single-cell RNA sequencing studies have identified transcriptomic differences, such as splicing variations in PTPRC (CD45), critical for T cell activation, and CLEC2D, associated with lymphocyte counts and pro-inflammatory states, which may contribute to immune dysregulation in RA (35, 36).